If you are using copyrighted QTdrugs information in your capacity as an employee or contractor for a commercial organization, such use is considered commercial by AZCERT's Terms of Use and, as such, requires a license. AZCERT's policy defines non-commercial use as any use by employees of government agencies, academic institutions, not-for-profit entities or self-employed healthcare providers. However, commercial use or reproduction of the QTdrugs lists or other copyrighted content from this website is prohibited unless authorized by AZCERT, Inc. The Subscription Agreement and Terms of Use are available here. Online orders can be placed here and quotations for licensing fees are available by contacting info@azcert.org.
The SADS Foundation just released a COVID-19 Vaccine statement that recommends that all individuals with SADS conditions receive a vaccination.
Michael J. Ackerman, MD, PhD, director of the Long QT Syndrome Clinic and professor of medicine,…
Three new drugs have been added and one removed from the Possible Risk of TdP category for the QTdrugs list.
Two drugs used for prostate cancer (Bicalutamide and Relugolix) and an antibiotic (Linezolid) have been added to the Possible Risk category.…
Today, Tuesday April 6th, AZCERT, the makers of CredibleMeds and MedSafety Scan, will participate in "Arizona Gives Day," a statewide online charitable giving event to inspire people to give generously to nonprofit organizations who make our state…
Text for citing the use of the QTdrugs lists or the CredibleMeds.org website:
Woosley RL, Heise CW , Gallo T, Tate J, Woosley D and Romero KA, www.CredibleMeds.org, QTdrugs List, [Accession Date], AZCERT, Inc. 1457 E. Desert Garden Dr., Tucson, AZ 85718
Copyright: The CredibleMeds® website is intended for personal and professional use only. Its content is protected by U.S. Copyright. Unauthorized use for commercial purposes is prohibited.
Print
Share
RSS
Donate
